MIGREN VA GIPERTENZIYAGA ZAMONAVIY QARASH, NEVROLOGNING KASBIY SALOHIYATI (ADABIY SHARHLASH)
##article.subject##:
migren, gipertoniya, bosh og‘rig‘i, migrenning asoratlari, migren va gipertogiya kasalligi patogenetik rivojlanishi##article.abstract##
Tadqiqot maqsadi. Gipertoniya kasalligi bilan og‘rigan bemorlarda migrenning tarqalishini o‘rganish, bosh og‘rig‘ining kelib chiqish omillari, klinik kechishining o‘ziga xos xususiyatlari, xorijiy tadqiqotchilarning kuzatuvlariga ko‘ra bosh og‘rig‘i sababli yuzaga kelishi mumkin bo‘lgan asoratlarni aniqlash, ilmiy tadqiqotlarni o‘rganish va adabiyotlarga tayangan holda olingan natijalar asosida tahliliy xulosa berish.
Tadqiqot materiallari va usullari. Adabiy sharhni tayyorlash uchun migren va gipertoniya mavzusidagi 100 dan ortiq tadqiqotlar ko‘rib chiqildi. Ko‘rib chiqilgan adabiyotlar AQSh, Yaponiya, Yevropa, Osiyo tadqiqotchilar ilmiy ishlariga mansub edi.
Natija va munozaralar. Tahliliy sharh gipertoniya bilan og‘rigan bemorlarda migren rivojlanishining epidemiologik, klinik va patogenetik xususiyatlaridan iborat bo‘lib barcha bosh og‘rig‘i etiopatogenetik kelib chiqishi tomir kasalligiga bog‘liq bo‘lgan surunkali bosh og‘rig‘i turiga kiritilganligi shohidi bo‘ldik. Ushbu bosh og‘riqlar butun umri davomida bemorni bezovta qiladi, boshqacha qilib u bilan birga hamroh bo‘ladi, yashaydi, xurujlar esa boshning teng yarmida paydo bo‘lib davriy yoki muntazamlik bilan tavsiflanadi va taxminan 1 mlrd aholi surunkali bosh og‘rig‘i bilan azoblanadi. JSST (2016) ma’lumotlariga ko‘ra, dunyoda 50 foiz inson yiliga kamida bir marta bosh og‘rig‘i bilan og‘riydi, ularning 30 foiziga migren deb tashxis qo‘yiladi. Umumiy populyatsiyada migrenning tarqalishi o‘rtacha 14,4 foiz (13,8 dan 15,0 foizgacha)ni tashkil etadi. Migrenning og‘ir kechishi nafaqat alomatlarning og‘irligi, balki uning mehnat qobiliyati, ijtimoiy faollik va oilaviy munosabatlarga ta’siri bilan ham bog‘liqligi isbotlangan.
Xulosa. Hamkor kasallik, ayniqsa gipertoniya kasalligi bilan birga kechadigan migren og‘ir klinik ko‘rinishga ega bo‘lib miyada og‘ir organik jarayon rivojlanishiga, miya tomirlarining erta zararlanishiga olib kelib uzoq davom etuvchi bosh og‘riq paroksizmlariga sabab bo‘ladi, gipoksik o‘zgarishlar, ensefalomalyatsiya paydo bo‘lishiga, qolaversa, qon- tomir-metabolik ensefalopatiyalarning rivojlanishiga sabab bo‘ladi.
Библиографические ссылки
Arca K.N., Halker Singh R.B.. SUNCT and SUNA: an update and re-view. Curr Pain Headache Rep. 2018;22(8):56.
Arca K.N., Halker Singh R.B. The hypertensive headache: a re-view. Curr Pain Headache Rep. 2019;23(5):30.
Ashina M., Katsarava Z., Do T.P., et al. Migraine: epidemiology and systems of care. Lancet. 2021 Apr 17;397(10283):1485-95. doi: 10.1016/S0140-6736(20)32160-7.
Ayzenberg I., Katsarava Z., Sborowski A., et al; Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide sur-vey. Cephalalgia. 2012 Apr; 32(5):373-81. doi: 10.1177/0333102412438977.
Babayan L., Oleg V., Mamontov O.V., Amelin A.V., Bogachev M., Kamshilin A.A. Arterial hypertension in migraine: role of familial history and cardiovascular phenotype. Autonom Neurosci Basic Clin. 2017; 203:103-107.
Courand P.Y., Serraille M., Girerd N., Demarquay G., Milon H., Lan-telme P., et al. The paradoxical significance of headache in hypertension. Am J Hypertens. 2016;29(9):1109–16.
Courand P.Y., Serraille M., Girerd N., Demarquay G., Milon H., Lan-telme P., et al. The paradoxical significance of headache in hypertension. Am J Hypertens. 2016;29(9):1109–16.
Do T.P., Remmers A., Schytz H.W., Schankin C., Nelson S.E., Ober-mann M., et al. red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134–44.
Entonen A.H., Suominen S.B., Korkeila K., Mantyselka P.T., Sil-lanmaki L.H., Ojanlatva A., et al. Migraine predicts hypertension—a cohort study of the Finnish working-age population. Eur J Pub Health. 2014;24(2):244–8.
Fagernaes C.F., Heuch I., Zwart J.A., Winsvold B.S., Linde M., Hagen K. Blood pressure as a risk factor for headache and migraine: a prospective population-based study. Eur J Neurol. 2015;22(1):156–62, e10-1 An im-portant longitudinal study to investigate whether hypertension predicts mi-graine (HUNT study).
Finocchi C, Sassos D. Headache and arterial hypertension. Neurol Sci. 2019;38(suppl 1):S67-S72. doi: 10.1007/s10072-017-2893-x
Friedman BW, Mistry B, West JR, Wollowitz A. The association be-tween headache and elevated blood pressure among patients presenting to an ED. Am J Emerg Med. 2014;32(9):976–81.
Gardener H, Monteith T, Rundek T, Wright CB, Elkind MS, Sacco RL. Hypertension and migraine in the Northern Manhattan Study. Ethn Dis. 2016;26(3):323–30.
Gudmundsson L.S., Thorgeirsson G., Sigfusson N., Sigvaldason H., Johannsson M. Migraine patients have lower systolic but higher diastol-ic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study // Cephalalgia. 2006 Apr;26(4):436-44. doi: 10.1111/j.1468-2982.2005.01057.x
Headache Classification Committee of the International Headache So-ciety (IHS) The International Classification of Headache Disorders, 3rd edi-tion. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202 .
Leonardi M, Raggi A. A narrative review on the burden of migraine: when the burden is the impact on people's life. J Headache Pain. 2019 Apr 25;20(1):41. doi: 10.1186/s10194-019-0993-0.
Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic man-agement of migraine in 2004, in France: results of FRAMIG 3, a French Na-tionwide Population-Based Suevey. Headache. 2006 May;46(5):715-25. doi: 10.1111/j.1526-4610.2006. 00430.x
Matei D, Constantinescu V, Corciova C, Ignat B, Matei R, Popescu CD. Autonomic impairment in patients with migraine. Eur Rev Med Phar-macol Sci. 2015;19(20):3922–7.
Miglist MG. Migraine and autonomic dysfunction: which is the horse and which is the jockey? Curr Pain Headache Rep. 2018;22(3):19.
M. Sanoeva, M. Gulova, S. Farruh, I. Amrillo, M. Avezova Compara-tive analysis of cognitive function at vascular complications of migraine (di-agnosis and clinical approach). Journal of Critical Reviews. 2020;7(3):425-430.
Olesen J. The role of nitric oxide (NO) in migraine, tension-type head-ache and cluster headache. Pharmacol Ther. 2008; 20:157-171.
Rist PM, Winter AC, Buring JE, Sesso HD, Kurth T. Migraine and the risk of incident hypertension among women. Cephalalgia. 2018;38(12):1817–24 An important longitudinal study to investigate wheth-er migraine predicts hypertension.
Ross S.J., Elgendy I.Y., Bavry A.A. Cardiovascular safety and bleed-ing risk associated with nonsteroidal anti-inflammatory medications in pa-tients with cardiovascular disease. Curr Cardiol Rep. 2017;19(1):8.
Sanoeva M.J. Structural Analysis of Headaches–Etiopathogenetic Foundations, Diagnostic Features Research Journal of Trauma and Disabil-ity Studies. 2023; 2 (12), 936-944
Sanoeva M.J. Signs of Cognitive Dysfunction in Patients with Multi-ple Sclerosis In Conditions of Covid-19. European Journal Of Modern Med-icine and Practice 2023; 3 (12), 258-264.
P. Nilufar, S.M. Jakhonkulovna. Predictors of Sleep Disorders in Pa-tients with Hypertension. Amaliy va tibbiyot fanlari ilmiy jurnali. 2023; 2 (9), 82-86.
Stovner L.J., Nichols E., Steiner T.J., et al. Global, regional, and na-tional burden of migraine and tension-type headache, 1990–2016: a system-atic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):954-76. doi: 10.1016/S1474-4422(18)30322-3
Stovner L., Hagen K., Jensen R., et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cepha-lalgia. 2007; 27(3):193-210. doi: 10.1111/j.1468-2982.2007. 01288.x
Stovner L.J., Linde M., Gravdahl G.B., Tronvik E., Aamodt A.H., Sand T., et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014;34(7):523–32.
van Oosterhout WP, Schoonman GG, Saal DP, Thijs RD, Ferrari MD, van Dijk JG. Abnormal cardiovascular response to nitroglycerin in migraine. Cephalalgia. 2020;40(3):266–77.
Whelton P.K., Carey R.M., Aronow W.S., Casey D.E. Jr, Collins K.J., Dennison Himmelfarb C., et al. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324.
Yilmaz Avci A., Akkucuk M.H., Torun E., Arikan S., Can U., Tekindal M.A. Migraine and subclinical atherosclerosis: endothelial dysfunc-tion biomarkers and carotid intima-media thickness: a case-control study. Neurol Sci. 2019;40(4):703–11.
